(Q37988965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

The B7 homologues and their receptors in hematologic malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Ryan A Wilcox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Stephen M Ansell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Weiping Zou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Lieping Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

28 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

465-475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22372959%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

cites work

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The new B7s: playing a pivotal role in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Fine tuning the immune response through B7-H3 and B7-H4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

LICOS, a primordial costimulatory ligand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-h2 is a costimulatory ligand for CD28 in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7x: a widely expressed B7 family member that inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7S1, a novel B7 family member that negatively regulates T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 signaling in primary T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Cancer-associated myeloproliferation: old association, new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Prognostic factors in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-h1 expressed by activated CD8 T cells is essential for their survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The molecular pathogenesis of primary mediastinal large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Follicular helper CD4 T cells (TFH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Advances in the understanding and management of angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

ICOS deficiency in patients with common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1 on dendritic cells impedes innate immunity against bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H4-deficient mice display augmented neutrophil-mediated innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Chronic neutropenia associated with autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X

New monoclonal antibodies against B-cell antigens: Possible new strategies for diagnosis of primary cutaneous B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01766.X